Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New data on Fujisawa's histone deacetylase inhibitor FR-901228

April 28, 2004

Novel cytotoxic agent effective against chemotherapy-resistant ovarian carcinoma

April 28, 2004

Synthetic truncated PSP94 for metastatic hormone-resistant prostate cancer patients

April 28, 2004

Preclinical studies shed light on molecular pathways of p53

April 27, 2004

SuperGen to submit Dacogen NDA on rolling basis

April 27, 2004

New CDK inhibitors developed by Schering-Plough and Pharmacopeia team

April 27, 2004

Antitubulin agent effective against tumor growth in vivo

April 27, 2004

Interim data from phase II clofarabine study in AML reveal complete responses

April 26, 2004

Phenoxodiol studied in new ovarian cancer trial

April 26, 2004

Advexin subject of new SWOG phase II trial

April 23, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...